Integra LifeSciences Holdings Corporation - Common Stock (IART)
Frequently Asked Questions About Integra LifeSciences Holdings Corporation - Common Stock (IART)
How can investors learn more about Integra LifeSciences?
Investors can learn more about Integra LifeSciences by visiting the company's official website, where they can access financial reports, press releases, and updates on products and corporate initiatives. The company also conducts regular investor meetings and presentations.
How does Integra approach research and development?
Integra invests heavily in research and development to innovate and improve its product offerings. The company collaborates with healthcare professionals, conducts clinical trials, and leverages emerging technologies to develop solutions that address the needs of patients and surgeons alike.
How does Integra engage with the medical community?
Integra engages with the medical community through partnerships, sponsorships, and participation in conferences and workshops. The company emphasizes collaboration with healthcare professionals to drive innovation and address clinical challenges.
How does Integra support healthcare professionals?
Integra offers extensive support to healthcare professionals through training and education programs. This includes providing resources, technical support, and assistance with product implementation to ensure optimal usage of its medical technologies.
Is Integra LifeSciences publicly traded?
Yes, Integra LifeSciences Holdings Corporation is publicly traded on the Nasdaq under the ticker symbol 'IART'. The company went public in 2000 and has since been included in various financial indices.
What are Integra's main markets?
Integra operates in several key markets, including neurosurgery, otolaryngology, orthopedics, and wound care. The company focuses on both the domestic U.S. market and international markets, adapting its products to meet local healthcare needs.
What are some recent acquisitions by Integra?
Integra has expanded its market presence through strategic acquisitions, including the 2020 acquisition of the ACell, Inc. and the 2021 acquisition of the company's regenerative medicine product lines. These strategic moves augment its portfolio and enable entrance into new markets.
What does Integra LifeSciences Holdings Corporation do?
Integra LifeSciences Holdings Corporation develops and manufactures medical devices and biologics for the surgical, neurotrauma, and regenerative medicine markets. Their products are designed to address unmet medical needs and improve patient outcomes in a variety of clinical settings.
What is Integra's commitment to sustainability?
Integra LifeSciences is committed to environmental sustainability and corporate social responsibility. The company actively seeks to minimize its environmental footprint through responsible sourcing, efficient operations, and engaging in community initiatives.
What is Integra's policy on clinical trials?
Integra adheres to ethical guidelines and best practices when conducting clinical trials. The company prioritizes patient safety, data integrity, and regulatory compliance throughout the research process to develop effective and safe medical products.
What is Integra's strategy for global expansion?
Integra's global expansion strategy involves entering emerging markets, establishing distribution partnerships, and adapting products to meet local regulatory requirements and patient needs. This approach allows the company to grow its international footprint effectively.
What is Integra's vision for the future?
Integra's vision for the future focuses on improving patient outcomes through innovative technologies while expanding its market reach. The company aims to remain a leader in the medical device space by continuously developing products that respond to the evolving needs of healthcare professionals and patients.
What is the significance of Integra's tissue regeneration products?
Integra's tissue regeneration products, particularly those using its proprietary collagen technology, are significant for their ability to facilitate natural wound healing and tissue regeneration beyond traditional methods. These innovative solutions are vital in addressing complex surgical needs.
What regulatory approvals does Integra require for its products?
Integra's products must undergo rigorous testing and receive regulatory approvals from agencies like the U.S. Food and Drug Administration (FDA) and international health authorities before they can be marketed and sold. Compliance with stringent regulations ensures product safety and efficacy.
What role does innovation play at Integra?
Innovation is central to Integra's mission, driving the development of new products and technologies. The company fosters a culture of creative problem-solving, investing in R&D to stay at the forefront of medical advancements and fulfill unmet patient needs.
What types of products does Integra offer?
Integra's product portfolio includes wound care management solutions, neurosurgical products, orthopedic devices, and regenerative tissue technologies. Each product line is aimed at enhancing recovery and improving surgical outcomes for patients in various healthcare settings.
When was Integra LifeSciences founded?
Integra LifeSciences was founded in 1989, initially focusing on the commercialization of products for neurosurgery. Over the years, the company has expanded its portfolio to include a wide range of surgical and regenerative medicine products.
Where is Integra LifeSciences headquartered?
Integra LifeSciences is headquartered in Princeton, New Jersey. This location serves as the central hub for their operations, which include research and development, manufacturing, and corporate functions.
Who are the primary customers of Integra LifeSciences?
Integra's primary customers include hospitals, surgical centers, and healthcare professionals such as surgeons and physicians who utilize their innovative medical devices and biologics in surgical procedures and treatments.
Who is Integra's competitor in the healthcare market?
Integra competes with several major companies in the medical device sector, including Medtronic, Stryker, and Johnson & Johnson. Each of these companies presents unique challenges and competition across various product categories.
What is the current price of Integra LifeSciences Holdings Corporation - Common Stock?
The current price of Integra LifeSciences Holdings Corporation - Common Stock is 20.06
When was Integra LifeSciences Holdings Corporation - Common Stock last traded?
The last trade of Integra LifeSciences Holdings Corporation - Common Stock was at 4:00 pm EDT on April 3rd, 2025
What is the market capitalization of Integra LifeSciences Holdings Corporation - Common Stock?
The market capitalization of Integra LifeSciences Holdings Corporation - Common Stock is 1.70B
How many shares of Integra LifeSciences Holdings Corporation - Common Stock are outstanding?
Integra LifeSciences Holdings Corporation - Common Stock has 84.58M shares outstanding.